aTyr Pharma to Present at Investor Conferences

SAN DIEGO, May 06, 2024 — aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical-stage biotechnology company focused on developing innovative treatments from its unique tRNA synthetase platform, announced that its President and CEO, Sanjay S. Shukla, M.D., M.S., will be presenting at several investor conferences in May and June 2024. Here are the details of the scheduled conferences:

1. RBC Capital Markets Global Healthcare Conference:
- Date: Wednesday, May 15, 2024
- Time: 8:00am EDT
- Location: New York, NY
- Format: Fireside Chat

2. Piper Sandler Virtual Lung Investor Day:
- Date: Thursday, May 23, 2024
- Time: 12:45pm EDT
- Location: Virtual
- Format: Fireside Chat

3. Jefferies Global Healthcare Conference:
- Date: Wednesday, June 5, 2024
- Time: 4:30pm EDT
- Location: New York, NY
- Format: Corporate Presentation

In addition to the main presentations, the management team from aTyr Pharma will be available for one-on-one meetings with investors attending the RBC and Jefferies conferences. Both the RBC and Jefferies events will be webcasted and can be accessed through the Investor’s section of aTyr Pharma’s website. Replays of these presentations will be available on the company's website for a minimum of 90 days after the events.

aTyr Pharma is a biotechnology company in the clinical stage, leveraging its expertise in tRNA synthetase biology to create new treatments for fibrosis and inflammation. tRNA synthetases are ancient proteins that have developed unique domains to regulate a variety of pathways in humans. The company's discovery platform aims to find new therapeutic intervention points by identifying signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases.

The lead therapeutic candidate of aTyr is efzofitimod, a pioneering biologic immunomodulator. It is currently in clinical trials for the treatment of interstitial lung disease, a group of immune-mediated disorders that can lead to inflammation and progressive lung fibrosis, or scarring. For more details, visit the aTyr Pharma website.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!